abnormalities in dermal connective tissue erik austin, d.o., m.p.h

97
ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H.

Post on 22-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

ABNORMALITIES INDERMAL CONNECTIVE TISSUE

Erik Austin, D.O., M.P.H.

Page 2: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Elastosis perforans serpiginosa – Serpiginous arrangement of confluent, keratotic papules on the arms, face/neck, legs

Page 3: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Keratotic papules of EPSTypical site affected = neck

Page 4: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Elastosis perforans serpiginosaEPS MC in young adults with a M:F ratio of 4:1 Runs a variable course of 6 mos to 5 years

with spontaneous resolution Associated with: Down Syndrome, Ehlers-

Danlos, osteogenesis imperfecta, Marfan’s, Rothmund-Thomson, acrogeria, systemic sclerosis

Tx = LN2, Penicillamine

Page 5: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Annular plaques of EPS

Atrophic scars often form

Page 6: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

EPS

Hyperelastic epidermis that clutches the increased dermal elastic fibers like a claw

Page 7: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

EPS

Transepidermal elimination of neutrophils and elastic fibers from the dermis through a channel in the epidermis

Page 8: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Reactive perforating collagenosis (RPC)Keratotic papules on upper extremity, face or buttocks

Page 9: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Reactive perforating collagenosisRPC Rare, familial, non-pruritic skin disorder Lesions begin in 2nd decade Involution occurs after 6-8 weeks, with new

crops appearing for years May be a reaction to trauma Acquired form may be assoc. w/systemic dz TX = treat underlying disease

Page 10: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Pseudoxanthoma elasticum (PXE)

Yellow papules, calcified plaques, sagging skin; chicken skin

Page 11: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Pseudoxanthoma elasticumPXE Inherited disorder of the skin, eyes, and

cardiovascular system Has recessive and dominant inheritance Exaggerated nasolabial folds is

characteristic Involvement of the cardiovascular system

occurs with a propensity to hemorrhage

Page 12: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Mucosal lesions

Retinal change = Angioid streaks; in up to 85%

Page 13: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Pseudoxanthoma elasticumPXE Mitral valve prolapse, 71% of 14 pts Young pt w/hypertension = r/o PXE Histo: mid-dermis w/elastic fibers that are

swollen and granular - “raveled wool” No distinctive therapy Limit dietary calcium and phosphorus

Page 14: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Histopathology of PXE

A. calcium deposits on elastic fibers in advanced PXE

B. irregularly clumped elastic fibers, Verhoeff van Giesson

Page 15: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Perforating calcific elastosis

Acquired, localized disorder Frequently found in obese, multiparous,

middle-aged women Yellowish, lax, well circumscribed,

reticulated or cobblestones plaques occur in the periumbilical region with keratotic papules

Page 16: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Perforating calcific elastosis

Shares features with PXE, without systemic features

Trauma of pregnancy, obesity or surgery promote elastic fiber degeneration

No effective therapy

Page 17: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Ehlers-Danlos syndromes

A group of genetically distinct disorders characterized by excessive stretchability and fragility of the skin

Tendency toward easy scar formation, calcification of the skin to produce, pseudotumors, and hyperextensibility of the joints

Page 18: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Clinical features of Ehlers-Danlos syndrome

Page 19: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Two types of growths seen with EDS Molluscum pseudotumor = a soft fleshy

nodule seen in areas of trauma Spheroids = hard subcutaneous nodules that

become calcified, ?Result of fat necrosis

Page 20: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Types I, II, III and one subtype each of types of IV, VII and possibly VIII = AD

One subtype of IV, VI, VII, and X = AR Type V = X-linked inheritance Treatment is supportive Avoidance of trauma

Page 21: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Marfan syndrome

AD Skeletal, cardiovascular, and ocular

involvement Important abnormalities include: tallness,

loose-joints, a dolichocephalic skull, high arched palate, arachnodactyly, pigeon breast, pes planus, poor muscular tone, large deformed ears

Page 22: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Ascending aortic aneurysm and mitral valve prolapse are commonly seen

Ectopic lentis and striae Gene defect = chromosome 15 Abnormal elastic tissue in fibrillin 1 and

fibrillin 2

Page 23: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Cutis Laxa – loose, hanging skin – usually entire integument is involved

Page 24: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Cutis laxa (generalized elastosis)

AD = primarily cutaneous, good prognosis AR = significant internal involvement, die young X-linked recessive = occipital horn syndrome Nonfamilial forms have been described May be associated with an underlying disease or

inflammatory skin process Mid-dermal elastosis is an acquired, nonfamilial

condition affecting primarily young women, cause unknown

Tx = disappointing; surgery is unsuccessful

Page 25: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Cutis laxa (generalized elastosis)

Premature aging, severe pulmonary emphysema, and fragmentation of dermal elastic fibers

Page 26: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Blepharochalasis

Lax eyelid skin due to swelling of lids Uncommon AD Lack of elastic fibers, and abundant IgA

deposits have been demonstrated Ascher Syndrome = progressive

enlargement of the upper lip and blepharochalasis / treatment is surgical

Page 27: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Anetoderma (macular atrophy)

A group of disorders characterized by looseness of the skin due to loss of elastic tissue

Page 28: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Anetoderma (macular atrophy)

Page 29: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 30: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Anetoderma – macular atrophy and atrophic plaques – buttonhole sign. Typical location: trunk, arms, shoulders, thighs

Page 31: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Anetoderma: decreased elastic fibers in the papillary and reticular dermis

Page 32: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Striae rubra, striae alba: depressed lines or bands

Page 33: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Striae distensae

Can occur secondary to pregnancy or after sudden weight gain or muscle mass

Associated with Cushing’s syndrome and Prolonged application of topical steroids Overtime striae become less noticeable Tx = topical tretinoin; vascular lasers

Page 34: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Linear focal elastosis(elastotic striae) Asymptomatic, palpable, striaelike yellow

line of the middle and lower back Distinguished from striae in that there is no

depression

Page 35: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Acrodermatitis chronica atrophicans Acquired diffuse thinning of the skin Reddish appearance on extensor surfaces Progresses to smooth , soft, atrophic skin Results from infection with Borrelia

Page 36: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Osteogenesis imperfecta

Affects: bones, joints, eyes, ears, and skin types I-IV, I and IV = AD II and III = AD/AR 50% are type I type II is lethal within 1st week of life Brittle bones, fractures occur early in life,

sometimes in utero Loose-jointedness and dislocations

Page 37: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Osteogenesis imperfecta

Blue sclera Deafness Thin skin; atrophic scars EPS has associated

Page 38: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Osteogenesis imperfecta

Defect is abnormal collagen synthesis, resulting in type I collagen of abnormal structure

Major causes of death = respiratory failure and head trauma

Type I and IV have a normal life span TX = Pamidronate

Page 39: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Homocystinuria

Inborn error in the metabolism if methionine

Homocystine in the urine and CT abnormalities

cystathionine synthetase deficient Genu valgum, kyphoscoliosis, pigeon

breast, frequent fractures

Page 40: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Homocystinuria

Facial skin has a characteristic flush Other skin is blotchy red Hair is fine, sparse and blonde Teeth are irregularly aligned Downward dislocations of lens TX = hydroxocobalamin and

cyanocobalamin – variable results

Page 41: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

ERRORS IN METABOLISM

Page 42: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

SYSTEMIC AMYLOIDOSISprimary systemic amyloidosis Involves mesenchymal tissue, the tongue,

heart, gastrointestinal, and skin Cutaneous manifestations in 40% Amyloid fibril proteins are composed of AL Derived from immunoglobulin light chains 90% will have fragment in urine and serum

Page 43: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 44: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 45: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

SYSTEMIC AMYLOIDOSISprimary systemic amyloidosis Waxy, firm, flat-topped or spherical papules Coalesce to form nodules and plaques Eyes, nose, mouth, and mucocutaneous

junctions are commonly involved Purpuric lesions and ecchymosis (15%) Results from amyloid infiltration of vessels

Page 46: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

SYSTEMIC AMYLOIDOSISprimary systemic amyloidosis Glossitis with macroglossia (20%) May cause dysphagia Bullous disease is rare and scarring Subepidermal: DDx PCT and EBA

Page 47: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

SYSTEMIC AMYLOIDOSISprimary systemic amyloidosis Systemic findings: peripheral neuropathies,

arthropathy, GI bleeding, cardiac disease Prognosis is poor, median survival 13 mos,

5 mos in myeloma associated cases Treatment is difficult = melphalen,

prednisone, hematopoietic stem cell transplantation

Page 48: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

primary systemic amyloidosis

Macroglossia with dental impression of the tongue

Page 49: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

primary systemic amyloidosis

Periorbital ecchymosis, “raccoon sign”

Page 50: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

primary systemic amyloidosis

Numerous waxy and translucent papules

Page 51: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Secondary systemic amyloidosis

Amyloid involvement of adrenals, liver spleen, and kidney as a result of some chronic disease (TB, leprosy, etc.)

Skin is not involved Amyloid fibrils are designated AA, protein

component is unrelated to immunoglobulin Treat the underlying condition

Page 52: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

CUTANEOUS AMYLOIDOSISprimary cutaneous amyloidosis Divided into macular and lichen amyloid Asian , Hispanic, and Middle Eastern Amyloid deposition contains keratin Histologic picture is similar for both Differ only in size of amyloid deposits Absence of amyloid deposits around blood

vessels excludes systemic involvement

Page 53: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Macular Amyloidosis: pruritic, brown macules with a rippled pattern

Page 54: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Lichen amyloidosis Pruritic, keratotic,

hyperigmented plaques on the legs

Tx = high potency corticosteroids, oral retinoids, cyclophosphamide, dermabrasion and occlusion

Page 55: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Nodular amyloidosis

Extremities, trunk, genitals and face with localized nodules

Lesions contain numerous plasma cells, amyloid is immunoglobulin-derived AL

TX = physical removal or destruction

Page 56: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 57: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Secondary cutaneous amyloidosis

Following PUVA therapy and in benign and malignant cutaneous neoplasms, deposits of amyloid may be found

Most frequently associated neoplasms are NMSC and SKs

In all cases, this is keratin-derived amyloid

Page 58: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Familial syndromes associated with amyloidosis (heredofamilial amyloidosis)

Muckle-Wells syndrome MEN IIA Most present with neurologic disease and

are now designated familial amyloidotic polyneuropathy

Four types identified FAP I through IV AD inherited

Page 59: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

PORPHYRIAS

Porphyrinogens are the building blocks of hemoproteins

Produced primarily in the liver, bone marrow and erythrocytes

Each form is associated with a deficiency in the metabolic pathway of heme synthesis

Page 60: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 61: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 62: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H
Page 63: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Absorption of UV radiation in the Soret band (400-410 nm) by the increased porphyrins leads to photosensitivity

Activated porphyrins form reactive oxygen species that causes tissue damage

Page 64: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Current grouping of the porphyrias is based on the primary site of increased porphyrin production Erythropoietic forms

Congenital erythropoietic porphyria (CEP)

Erythropoietic protoporphyria (EPP)

Erythropoietic coproporphyria ECP

Hepatic forms Acute intermittent

porphyria (AIP) ALA dehydrogenase

deficiency Hereditary

coproporphyria (HCP) Variegate porphyria

(VP) Porphyria cutanea

tarda

Page 65: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Porphyria cutanea tarda

Most common porphyria Photosensitivity leads to bullae, which leads

to ulcers, scarring, milia and dyspigmentation

Hypertrichosis, fragility and skin thickening

Page 66: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Alcoholism is common; Hep C in 94% Associated with DM, LE, HIV, and

estrogen therapy

Page 67: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Multiple erosions with hemorrhagic crusts, as well as an intact blister on the lateral fourth finger

Page 68: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

PCT in chronic renal failure

Page 69: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

PCT

Page 70: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Deficiency = uroporphyrinogen decarboxylase

Most common = sporadic nonfamilial form, (80%), abnormal enzyme activity

Presents in midlife Familial type = AD; deficiency in liver and

RBCs Nonfamilial = acquired toxic; associated

with exposure to hepatotoxins

Page 71: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Diagnosis = suspected on clinical grounds Coral red fluorescence of urine 24 hour urine Uroporphyrins to coproporphyrins 3:1 to 5:1 DIF shows IgG and C3 at the DEJ, and in the

vessel walls in a linear pattern

Page 72: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Histologic features of PCT

Subepidermal blister with minimal dermal inflammatory infiltrate. Festooning of dermal papillae.

Page 73: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

treatment

Remove environmental exposures Sunscreens Phlebotomy / uroporphyrinogen

decarboxylase is inhibited by iron 500 ml at 2 week intervals, hemoglobin 10 g/dL Several months, 6-10 phlebotomies

Antimalarials / full doses may produce severe hepatotoxic reaction

Page 74: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Remission may last for years Iron chelation May respond to transplant in renal failure May improve with treatment if assoc. with

Hep C

Page 75: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

pseudoporphyria

Skin and Histo similar to PCT Normal urine and serum porphyrins No hypertrichosis, dyspigmentation or

cutaneous sclerosis Commonly caused by NSAIDs, naproxen,

sunbed use, hemodialysis

Page 76: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

treatment

Sun protection Discontinue inciting medication

May resolve over several months

Page 77: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Hepatoerythropoietic porphyria

Very rare form / AR Deficiency of uroporphyrinogen

decarboxylase, 10% of normal in both the liver and erythrocytes

Dark urine at birth Vesicles, scarring, hypertrichosis,

pigmentation, red fluorescence of teeth

Page 78: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Abnormal urinary porphyrins as in PCT Elevated erythrocyte protoporphyrins Increased coproporphyrins

Page 79: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Hepatoerythropoietic porphyria

Page 80: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Acute intermittent porphyria

Second most common form Characterized by periodic attacks of

abdominal colic, gastrointestinal disturbances, paralyses, and psychiatric disorders

No skin lesions are seen AD / deficiency in porphobilinogen

deaminase Only 10 % develop disease, all are at risk for

primary liver cancer

Page 81: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Severe abdominal colic +/- NVDC Elevated urinary porphobilinogen Increased dALA in plasma and urine No specific treatment Avoid precipitating factors Glucose loading

Page 82: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Hematin infusions Pain management Oral contraceptives may prevent attacks in

women with premenstrual symptoms

Page 83: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Hereditary coproporphyriaHCP Rare, AD Deficiency of coproporphyrinogen oxidase One third are photosensitive Prone to GI attacks Fecal coproporphyrin is always increased Urinary coproporphyrin, ALA, and PBG are

only increased during attacks

Page 84: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Variegate porphyriaVP AD Decreased activity of protoporphyrinogen

oxidase Majority of relatives have silent VP Characterized by skin lesions of PCT and

the GI and neurologic disease of AIP

Page 85: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Suspect VP when finding indicate both PCT and AIP, esp. with history of South African ancestry

Fecal coproporphyrins and protoporphyrins are always elevated

During attacks, urine porphobilinogen and ALA are elevated

Urinary coproporphyrins are increased over uroporphyrins

Page 86: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

A finding in the plasma of “X porphyrin,” fluorescence at 626 nm is characteristic and distinguishes this form from others

Symptomatic treatment as for PCT and AIP

Page 87: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Erythropoietic protoporphyriaEEP AD and AR forms Ferochelatase activity is 10 to 25% of

normal in affected persons Typically presents in childhood, 2-5 years Burning of the skin upon sun exposure Elevated protoporphyrin IX absorbs both

the Soret band and also at 500-600 nm

Page 88: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Severe liver disease in 10% Excessive porphyrins are deposited in liver Diagnosis on clinical grounds Urine porphyrin levels are normal Erythrocyte protoporphyrin is elevated Erythrocyte, plasma, and fecal protoporphyrin

can be assayed to confirm the diagnosis

Page 89: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Skin biopsy confirms diagnosis Tx = sun protection Beta carotene, phototherapy, cysteine Transfusions for anemia

Page 90: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Erythropoietic protoporphyria

Subtle scarring

Page 91: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Erythropoietic protoporphyria

Erythema and hemorrhagic crusts

Page 92: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Congenital erythropoietic porphyria, CEP Gunther’s disease AR; defect of uroporphyrinogen III

synthase Presents after birth with red urine Severe photosensitivity Blistering, scarring, ectropion and corneal

damage

Page 93: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Mutilating scars, hypertrichosis, profuse eyebrows, long eyelashes, “monkey face”

Growth retardation, hemolytic anemia, thrombocytopenia, porphyrin gallstones, osteopenia

Suspect in an infant with dark urine and photosensitivity

Page 94: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Congenital erythropoietic porphyria

Erythrodontia Severe mutilation

Page 95: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Fluorescence of circulating red blood cells, CEP with UVA

Vs. transient fluorescence in EPP

Page 96: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

High amounts of uroporphyrin I and coproporphyrin I are found in the urine, stool and red cells

Treatment – strict avoidance of sunlight and sometimes splenectomy for the hemolytic anemia

Oral activated charcoal Repeated transfusions to maintain

hematocrit level at 33% - turns off demand for heme

Bone marrow transplantation

Page 97: ABNORMALITIES IN DERMAL CONNECTIVE TISSUE Erik Austin, D.O., M.P.H

Transient erythroporphyria of infancy (purpuric phototherapy-induced eruption) Report of seven infants exposed to 380 to

700 nm blue lights, for the treatment of indirect hyperbilirubinemia, who developed marked purpura on the exposed skin

All infants had received transfusions Elevated plasma coproporphyrins and

protoporphyrins were found in 4 Pathogenesis is unknown